Skip to content

Fertility Philippines

Home » Can PGT-A Help Reduce The Risk Of Genetic Conditions In Children?

Can PGT-A Help Reduce The Risk Of Genetic Conditions In Children?

Preimplantation genetic testing (PGT) is usually recommended for patients with recurrent pregnancy loss, advanced maternal age, or a history of chromosomal abnormalities. When an embryo has extra or missing chromosomes, the resulting imbalance can interfere with its development leading to miscarriage. About 80% of pregnancy losses occur in the first trimester and are often linked to aneuploidy.

However, if the pregnancy continues, it can result in the birth of a child with a chromosomal condition. According to the World Health Organization, approximately 7.9 million babies worldwide are born each year with genetic or partially genetic conditions that can affect a person’s physical development, health, or ability to learn, with effects ranging from mild to life-threatening.

For individuals and couples undergoing in vitro fertilization (IVF), preimplantation genetic testing for Aneuploidy (PGT-A) can help screen embryos for certain chromosomal conditions before transfer to the uterus.

How Does PGT-A Help Reduce Risk Of Genetic Conditions

At Fertility Philippines, we offer PGT-A (Preimplantation Genetic Testing for Aneuploidy), which screens embryos for extra (trisomy) or missing (monosomy) chromosomes from the usual 46 chromosomes arranged in 23 pairs. One example is trisomy 21, which causes Down syndrome and can affect physical development and learning. In the Philippines, estimates suggest Down syndrome occurs in around one in every 800 births.

Other examples include trisomy 18 (Edwards syndrome), which can cause severe developmental delays, congenital heart defects, and feeding difficulties, and trisomy 13 (Patau syndrome), which can lead to brain and spinal cord abnormalities, heart defects, and cleft lip or palate. Monosomy X (Turner syndrome), involving a missing or partially missing X chromosome, can cause short stature, delayed puberty, and reduced fertility.

With the screening results, fertility specialists choose the best embryo for transfer by identifying those without detected chromosomal abnormalities, potentially reducing both the risk of miscarriage and having a child with certain chromosome-related conditions.

But beyond testing for chromosomal abnormalities, PGT-A can also identify chromosomal sex. Embryos with XX chromosomes are identified as female, while those with XY chromosomes are identified as male. This allows intended parents to know an embryo’s predicted chromosomal sex before transfer and select preferred gender for family balancing or certain medical reasons.

When Is PGT-A Performed During IVF

In an IVF treatment, the fertilized egg develops in the laboratory until it reaches the blastocyst stage, usually five to seven days after fertilization. If PGT-A is recommended, a specialist collects a few cells from the embryo for genetic analysis. The embryos are then preserved through vitrification, a rapid-freezing method, while the samples undergo testing, which takes around 14 days. Once the results are available, the fertility specialist can discuss the findings and plan the next steps in treatment.

Consult with us today to learn if PGT-A is right for your IVF journey.

Recommendations